One wrong field travels far.
A medicine has a different name, strength and marketing authorisation holder in every country where it is registered. Doctors and students look medicines up every day, in places you don’t control. When a holder, a group link or a product name is wrong, nobody tells you, and the mistake gets copied. The questions they are left with rarely get to your Medical Information team.
United States
- Product nameDiffers
- ANORO ELLIPTA
- StrengthDiffers
- 0.0625MG BASE/INH; 0.025MG BASE/INH
- FormDiffers
- POWDER
- Authorisation holderDiffers
- GLAXOSMITHKLINE
Canada
- Product nameDiffers
- ANORO ELLIPTA
- StrengthDiffers
- 62.5 MCG / ACT + 25 MCG / ACT
- FormDiffers
- Powder
- Authorisation holderDiffers
- GLAXOSMITHKLINE INC
Spain
- Product nameDiffers
- ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)
- StrengthDiffers
- 74,2 µg + 40 µg
- FormDiffers
- POLVO PARA INHALACIÓN (UNIDOSIS)
- Authorisation holderDiffers
- Glaxosmithkline (Ireland) Limited




